Recent Finacing
Recent Raise
Hygeia Therapeutics develops topical synthetic hormonal therapies, advancing HYG-102 (a topical estrogen for vaginal atrophy and age-related skin thinning) and developing HYG-440, a topical anti-androgen.
Focus Areas
Total Raised
Funding round